Showing 3211-3220 of 7903 results for "".
The Clinical Impact of Color LED Topographic Variability Analysis
https://crstoday.com/topics/general/the-clinical-impact-of-color-led-topographic-variability-analysis/42758/An ongoing evaluation of large data sets to improve patients' outcomes.Proper Toric IOL Alignment Begins With Centration
https://crstoday.com/topics/general/proper-toric-iol-alignment-begins-with-centration/42754/The ABCs of positioning toric IOLs.Accurate Results and High Premium IOL Conversions
https://crstoday.com/topics/general/accurate-results-and-high-premium-iol-conversions/42741/Careful patients' and staff education help patients select the best technology available.Establishing Your Brand
https://crstoday.com/topics/general/establishing-your-brand/42729/Highlighting the use of unique technology differentiates your practice from the pack.Visual Fields and OCT Scans Disagree
https://crstoday.com/topics/general/visual-fields-and-oct-scans-disagree/42727/Which do I believe? It depends.Sidebar: A Calculated Approach to Acute Conjunctivitis
https://crstoday.com/topics/general/sidebar-a-calculated-approach-to-acute-conjunctivitis/42722/Take consistent, measured steps to achieve better outcomes and reduce contagion.Cutting-Edge Diagnostic Technologies Foster Patients' Confidence
https://crstoday.com/topics/general/cutting-edge-diagnostic-technologies-foster-patients-confidence/42721/Point-of-care tests enable physicians to be better caregivers.A New Approach to the Rhino in the Room
https://crstoday.com/topics/general/a-new-approach-to-the-rhino-in-the-room/42718/Integrin peptide therapy offers the hope of a better treatment of two of the most significant and sight-threatening conditions in ophthalmology: AMD and DME.A Strategic Partner in Product Development
https://crstoday.com/topics/general/a-strategic-partner-in-product-development/42715/Questions and answers with Ora.Descemet Stripping Endothelial Keratoplasty
https://crstoday.com/topics/general/descemet-stripping-endothelial-keratoplasty/42701/The new standard in treating corneal endothelial disease.